Clinical Trial Update: A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder [Phase 3]

View source ↗

Summary

A multicenter Phase 3 trial evaluated the efficacy and safety of OROS methylphenidate HCl, Ritalin, and placebo in children with Attention Deficit Hyperactivity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• OROS Methylphenidate HCl (methylphenidate hydrochloride (extended-release))
• Ritalin (methylphenidate)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED